Trial Profile
Evaluation d'Une strategie therapeutique d'Association medicamenteuse Pour la Prise en Charge de la Maladie d'Alzheimer et Des Maladies apparentees au Stade modere.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Colecalciferol
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- Acronyms AD-IDEA
- 21 Sep 2016 Status changed from recruiting to completed.
- 20 Oct 2011 Study protocol published in Trials.
- 11 Oct 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.